id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0150-0001,FDA,FDA-2008-D-0150,Draft Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims; Availability,Notice,NAD-Notice of Availability of Data,2008-03-13T04:00:00Z,2008,3,2008-03-13T04:00:00Z,2008-05-13T03:59:59Z,2008-05-12T07:28:00Z,E8-05083,0,0,09000064803f402e
FDA-2008-D-0150-0002,FDA,FDA-2008-D-0150,Draft Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims - Guidance Document,Other,,2008-03-13T00:00:00Z,2008,3,,,2020-01-29T20:57:08Z,,0,1,09000064803f416f